Cargando…
Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer
BACKGROUND: Genetic intratumoral heterogeneity (ITH) hinders biomarker development in metastatic clear cell renal cancer (mccRCC). Epigenetic relative to genetic ITH or the presence of consistent epigenetic changes following targeted therapy in mccRCC have not been evaluated. The aim of this study w...
Autores principales: | Stewart, Grant D., Powles, Thomas, Van Neste, Christophe, Meynert, Alison, O'Mahony, Fiach, Laird, Alexander, Deforce, Dieter, Van Nieuwerburgh, Filip, Trooskens, Geert, Van Criekinge, Wim, De Meyer, Tim, Harrison, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041900/ https://www.ncbi.nlm.nih.gov/pubmed/27029034 http://dx.doi.org/10.18632/oncotarget.8308 |
Ejemplares similares
-
Haplotyping pharmacogenes using TLA combined with Illumina or Nanopore sequencing
por: Tilleman, Laurentijn, et al.
Publicado: (2022) -
Illumina sequencing of 15 deafness genes using fragmented amplicons
por: Van Nieuwerburgh, Filip, et al.
Publicado: (2014) -
The Efficacy of Sunitinib Treatment of Renal Cancer Cells Is Associated with the Protein PHAX In Vitro
por: Al-Lamki, Rafia S., et al.
Publicado: (2020) -
Combining in silico prediction and ribosome profiling in a genome-wide search for novel putatively coding sORFs
por: Crappé, Jeroen, et al.
Publicado: (2013) -
Kidney in VHL disease: Early clear cell proliferation occurs in the distal tubular system
por: Al-Gharaibeh, Nayef S., et al.
Publicado: (2022)